Biocompatibility for Medical Devices is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.


Christian Pellevoisin
Scientific Director at Episkin Academy


Involved for several years in development and promotion of in vitro toxicology assays based on reconstructed human tissues.

After a PhD in neuroscience at the French National Institute of Health and Medical Research (INSERM) he held a temporary teaching position at the university of Tours (France). He joined L’Oréal R&I in 2000 at the Life Science Research Center where he managed in silico tools for alternative approaches in toxicology (results database, Expert systems).

In 2004 he was appointed to scientific communication on alternative methods to animal testing and tissue engineering. In 2011 he joined EPISKIN, a subsidiary of L’Oréal, dedicated to development and production of reconstructed human epithelia. He developed the EPISKIN Academy program to support the use of 3D models for efficiency and safety assessment of chemicals, cosmetics, medical devices and to relay EPISKIN commitments to 3Rs. He conducted scientific collaborations with cosmetics, pharma and medical device industry partners leading to several publications.

Others: Chairman of the French AFNOR S92J commission of  biocompatibility of medical devices. Convenior of the WG8 skin irritation and sensitization of the ISO/TC194 for biocompatibility of medical devices. He is also L’Oreal R&I Research associate.

Christian Pellevoisin's Network

Agenda Sessions

  • Assessing alternatives to animal testing: Changing the paradigm from in vivo to in vitro toxicology